Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin treatment of patients with hand osteoarthritis
2023-509181-38-00Phase 3Authorised
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Metformin Orifarm with Placebo (2 arms). Primary endpoint: Change from baseline in VAS finger joint pain of the target hand at week 17. Planned start Apr 2024; status: authorised.
02
Drugs
metformin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2023-509181-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509181-38-00.